Literature DB >> 12844378

Restoration of the integrity of rat caeco-colonic mucosa by resistant starch, but not by fructo-oligosaccharides, in dextran sulfate sodium-induced experimental colitis.

Noëlle M Moreau1, Lucile J Martin, Claire S Toquet, Christian L Laboisse, Patrick G Nguyen, Brigitte S Siliart, Henri J Dumon, Martine M J Champ.   

Abstract

Butyrate is recognised as efficient in healing colonic inflammation, but cannot be used as a long-term treatment. Dietary fibre that produces a high-butyrate level when fermented represents a promising alternative. We hypothesised that different types of dietary fibre do not have the same efficiency of healing and that this could be correlated to their fermentation characteristics. We compared short-chain fructo-oligosaccharides (FOS) and type 3 resistant starch (RS) in a previously described dextran sulfate sodium (DSS)-induced colitis model. Seventy-two Sprague-Dawley rats received water (control rats) or DSS (50 g DSS/l for 7 d then 30 g DSS/l for 7 (day 7) or 14 (day 14) d). The rats were fed a basal diet (BD), or a FOS or RS diet creating six groups: BD-control, BD-DSS, FOS-control, FOS-DSS, RS-control and RS-DSS. Caeco-colonic inflammatory injuries were assessed macroscopically and histologically. Short-chain fatty acids (SCFA) were quantified in caeco-colon, portal vein and abdominal aorta. At days 7 and 14, caecal and distal macroscopic and histological observations were improved in RS-DSS compared with BD-DSS and also with FOS-DSS rats. Caeco-colonic SCFA were reduced in FOS-DSS and RS-DSS groups compared with healthy controls. The amount of butyrate was higher in the caecum of the RS-DSS rats than in the BD-DSS and FOS-DSS rats, whereas distal butyrate was higher in FOS-DSS rats. Partially explained by higher luminal levels of SCFA, especially butyrate, the healing effect of RS confirms the involvement of some types of dietary fibre in inflammatory bowel disease. Moreover, the ineffectiveness of FOS underlines the importance of the type of dietary substrate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12844378     DOI: 10.1079/bjn2003867

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  23 in total

1.  Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?

Authors:  P Marteau
Journal:  Gut       Date:  2006-12       Impact factor: 23.059

Review 2.  Probiotics and prebiotics in chronic inflammatory bowel diseases.

Authors:  Julia B Ewaschuk; Levinus A Dieleman
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

Review 3.  Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.

Authors:  Dimitrios Damaskos; George Kolios
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

4.  Fructooligosaccharides exert intestinal anti-inflammatory activity in the CD4+ CD62L+ T cell transfer model of colitis in C57BL/6J mice.

Authors:  Fermín Capitán-Cañadas; Borja Ocón; Carlos José Aranda; Andrea Anzola; María Dolores Suárez; Antonio Zarzuelo; Fermín Sánchez de Medina; Olga Martínez-Augustin
Journal:  Eur J Nutr       Date:  2015-07-08       Impact factor: 5.614

5.  Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis.

Authors:  Federico Lara-Villoslada; Oscar de Haro; Desire Camuesco; Mónica Comalada; Javier Velasco; Antonio Zarzuelo; Jordi Xaus; Julio Galvez
Journal:  Eur J Nutr       Date:  2006-07-26       Impact factor: 5.614

6.  Anti-inflammatory effects of newly synthesized α-galacto-oligosaccharides on dextran sulfate sodium-induced colitis in C57BL/6J mice.

Authors:  Zhuqing Dai; Simin Feng; Anna Liu; Hong Wang; Xiaoxiong Zeng; Chung S Yang
Journal:  Food Res Int       Date:  2018-04-24       Impact factor: 6.475

7.  MUC genes are differently expressed during onset and maintenance of inflammation in dextran sodium sulfate-treated mice.

Authors:  C Hoebler; E Gaudier; P De Coppet; M Rival; C Cherbut
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

8.  Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects.

Authors:  Inés Martínez; Jaehyoung Kim; Patrick R Duffy; Vicki L Schlegel; Jens Walter
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

Review 9.  The interplay between fiber and the intestinal microbiome in the inflammatory response.

Authors:  Shiu-Ming Kuo
Journal:  Adv Nutr       Date:  2013-01-01       Impact factor: 8.701

10.  Plant-derived polysaccharide supplements inhibit dextran sulfate sodium-induced colitis in the rat.

Authors:  Lee Koetzner; Gary Grover; Jamie Boulet; Henry I Jacoby
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.